We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

288:HKEXWH Group Ltd. (HK) Analysis

Data as of 2026-03-14 - not real-time

HK$164.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Standard Chartered is trading at a valuation that sits comfortably below its industry peers, with a price‑to‑earnings multiple that suggests the stock is undervalued relative to the broader banking sector. Fundamentals are reinforced by a solid dividend yield, a modest payout ratio and record earnings growth highlighted in the latest earnings call, where the wealth business posted robust expansion. The bank’s return on tangible equity is strong, and its capital base remains ample despite a high cash balance offset by sizable debt. Technical indicators show the stock near a key support level, with an RSI that points to oversold conditions and a bearish MACD divergence, while volume is on the rise, hinting at possible buying interest.
The overall risk profile reflects low market beta and a diversified geographic footprint, though exposure to emerging markets adds a moderate geographic and regulatory risk component. Volatility is elevated, but liquidity appears solid given the high market cap and active trading. The combination of attractive valuation, sustainable dividend and positive earnings momentum supports a favorable outlook across multiple horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Oversold RSI suggests potential near‑term bounce
  • Price is hovering at a critical support level
  • Rising trading volume indicates growing interest

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to peers
  • Strong earnings growth and wealth segment expansion
  • Attractive dividend yield with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend policy
  • Diversified geographic exposure across emerging markets
  • Robust capital position and solid return on equity

Key Metrics & Analysis

Financial Health

Revenue Growth2.30%
Profit Margin25.09%
P/E Ratio11.1
ROE9.63%
ROA0.58%
P/B Ratio1.0
Op. Cash FlowHK$-34529001472
Industry P/E16.4

Technical Analysis

TrendNeutral
RSI33.5
SupportHK$164.40
ResistanceHK$201.80
MA 20HK$184.33
MA 50HK$190.68
MA 200HK$159.04
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target PriceHK$212.87
Upside/Downside29.41%
GradeUndervalued
TypeBlend
Dividend Yield2.91%

Risk Assessment

Beta0.65
Volatility45.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.